We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biomarkers May Predict Zika-Related Birth Defects

By LabMedica International staff writers
Posted on 13 Nov 2018
To date, approximately 800,000 cases of suspected and confirmed autochthonous Zika virus (ZIKV) infections have been reported in the Americas. More...
Most people infected with the Zika virus experience no symptoms or mild illness with low-grade fever.

However, fetuses exposed to Zika in the womb are at risk for devastating neurological defects. One of those defects, microcephaly, a smaller-than-usual head size, gained prominence in 2015 with Brazil reporting an unusual number of cases in babies born to mothers infected with the virus.

Scientists from the University of Southern California (Los Angeles, CA, USA) and their colleagues obtained peripheral blood specimens from pregnant women aged 16–46 years old: healthy pregnant controls in non-ZIKV endemic Los Angeles, and healthy pregnant controls, as well as symptomatic ZIKV+ subjects in ZIKV-endemic Rio de Janeiro. Pregnancy was categorized into three trimesters based on the following: first trimester ≤13 weeks, second trimester 14–28 weeks and third trimester ≥29 weeks.

The team performed viral load detection of ZIKV in sera and urine specimens using qRT-PCR assays with the QuantiTect Probe RT-PCR kit. Multiplex immunoassays and enzyme-linked immunosorbent assay (ELISAs) were performed on serum specimens using Bio-Plex Pro human inflammation (37-plex) and chemokine (40-plex) panel assays and CCL2, and TNFRSF1A, CD163 and CCL22 ELISAs.

The investigators reported that extensive multiplexing analysis of 69 cytokines revealed that CXCL10, CCL2, and CCL8 chemokines were specifically associated with symptomatic ZIKV+ infection during pregnancy, and distinct immunoprofiles were detected at different trimesters in ZIKV-infected pregnant women. Intriguingly, the high CCL2 level and its inverse correlation with CD163, TNFRSF1A, and CCL22 levels was apparently associated with ZIKV-induced abnormal birth.

Weiqiang Chen, PhD, a research associate and co-author of the study, said, “Ultrasound is routinely used during pregnancy to check a baby's condition, but there's a limit to what can be seen. Magnetic resonance imaging can give clear, high-resolution 'snapshots' of the fetus, but there are safety concerns for the baby and it is recommended for second- and third-trimester pregnancy. Our findings identified a panel of biomarkers which may potentially be useful in predicting Zika-associated fetal outcomes regardless of pregnancy stages, simply by evaluating the mothers' blood.” The study was published on November 2, 2018, in the Journal of Clinical Investigation Insight.

Related Links:
University of Southern California


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.